Key facts
- This page summarizes Barbara K. Finck's Form 4 filing for Forte Biosciences, Inc. (FBRX).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 21 Mar 2025, 16:37.
Barbara K. Finck - 19 Mar 2025 Form 4 Insider Report for Forte Biosciences, Inc. (FBRX)
- Reporting relationship
- Director
- Issuer ticker
- FBRX
- Reported as of
- 19 Mar 2025
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 21 Mar 2025, 16:37:43 UTC
- Prior SEC filing
- 22 Aug 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Paul A. Wagner, Ph.D., as Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Barbara K. Finck filed Form 4 for Forte Biosciences, Inc. (FBRX) on 21 Mar 2025.
Change
- Previous filing in this sequence was filed on 22 Aug 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
FBRX
transaction
Derivative
Stock Option (right to buy)
Award
- Transaction value
- $0
- Shares
- +31,000
- Change %
- Price
- $0.000000
- Shares after
- 31,000
- Date
- 19 Mar 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 31,000
- Exercise price
- $7.02
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through each applicable vesting date, one thirty-sixth (1/36th) of the total shares subject to the option shall vest every month following the Vesting Commencement Date such that all shares shall be fully vested on the three (3) year anniversary of the Vesting Commencement Date. "Vesting Commencement Date" shall mean January 1, 2025.